282 related articles for article (PubMed ID: 25261936)
21. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
22. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas.
Herrero C; Brea J; Pérez-Díaz A; Cuadrado E; Ferreño N; Moiola CP; Colás E; Gil-Moreno A; López-López R; Loza MI; Abal M; Alonso-Alconada L
Biomed Pharmacother; 2021 Aug; 140():111744. PubMed ID: 34049223
[TBL] [Abstract][Full Text] [Related]
23. Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer.
Liao Y; He X; Qiu H; Che Q; Wang F; Lu W; Chen Z; Qiu M; Wang J; Wang H; Wan X
BMC Cancer; 2014 Jul; 14():487. PubMed ID: 24997474
[TBL] [Abstract][Full Text] [Related]
24. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
[No Abstract] [Full Text] [Related]
25. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneous Manifestations of Epithelial-Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients.
Tashireva LA; Savelieva OE; Grigoryeva ES; Nikitin YV; Denisov EV; Vtorushin SV; Zavyalova MV; Cherdyntseva NV; Perelmuter VM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801519
[TBL] [Abstract][Full Text] [Related]
27. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
28. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
[TBL] [Abstract][Full Text] [Related]
29. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
30. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
Aktas B; Tewes M; Fehm T; Hauch S; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(4):R46. PubMed ID: 19589136
[TBL] [Abstract][Full Text] [Related]
31. The role of WWOX tumor suppressor gene in the regulation of EMT process via regulation of CDH1-ZEB1-VIM expression in endometrial cancer.
Płuciennik E; Nowakowska M; Pospiech K; Stępień A; Wołkowicz M; Gałdyszyńska M; Popęda M; Wójcik-Krowiranda K; Bieńkiewicz A; Bednarek AK
Int J Oncol; 2015; 46(6):2639-48. PubMed ID: 25892250
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
[TBL] [Abstract][Full Text] [Related]
33. Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer.
Sadłecki P; Jóźwicki J; Antosik P; Walentowicz-Sadłecka M
Biomed Res Int; 2020; 2020():4584250. PubMed ID: 33457409
[TBL] [Abstract][Full Text] [Related]
34. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Lowes LE; Allan AL
Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
[TBL] [Abstract][Full Text] [Related]
35. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
[TBL] [Abstract][Full Text] [Related]
36. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
[TBL] [Abstract][Full Text] [Related]
37. The EMT signaling pathways in endometrial carcinoma.
Colas E; Pedrola N; Devis L; Ertekin T; Campoy I; Martínez E; Llauradó M; Rigau M; Olivan M; Garcia M; Cabrera S; Gil-Moreno A; Xercavins J; Castellvi J; Garcia A; Ramon y Cajal S; Moreno-Bueno G; Dolcet X; Alameda F; Palacios J; Prat J; Doll A; Matias-Guiu X; Abal M; Reventos J
Clin Transl Oncol; 2012 Oct; 14(10):715-20. PubMed ID: 22911547
[TBL] [Abstract][Full Text] [Related]
38. Enumeration, characterisation and clinicopathological significance of circulating tumour cells in patients with colorectal carcinoma.
Hamid FB; Lu CT; Matos M; Cheng T; Gopalan V; Lam AK
Cancer Genet; 2021 Jun; 254-255():48-57. PubMed ID: 33610860
[TBL] [Abstract][Full Text] [Related]
39. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
40. Correlation Research of Thymidine Synthase Expression in Circulating Tumor Cell and Clinical Characteristics of Colon Cancer.
Jiang Y; Liu K; Shi Y; Li Y; Ji X; Zhao R
Ann Clin Lab Sci; 2020 Jul; 50(4):439-446. PubMed ID: 32826238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
